Tranexamic Acid "Maxna" (by gul nawaz khan)

Post on 30-Jun-2015

680 views 6 download

description

Details of blood, hemostasis, clotting factors, heavy menstrual bleeding, causes of heavy menstrual bleeding, treatment options of heavy menstrual bleeding and menorrhagia, mode of action of tranexamic acid.

Transcript of Tranexamic Acid "Maxna" (by gul nawaz khan)

GNK 1

BLOODMENORRHAGIAHEMOSTASIS

MAXNA (The Product)

Blood is a specialized body fluid. Blood is the fluid pumped by the heart

that circulates throughout the body via the arteries, veins, and capillaries

Blood is a connective tissue. It provides communication between the cells of different part of the body and the external environment.

An adult male of average size normally has about 5.6 liters of blood

GNK 3

The blood carries oxygen and nutrients to the body tissues and removes carbon dioxide and other wastes

GNK 4

Fluid, known as Plasma.(55%)

Blood cells(45%), (Red cells, White cells, Platelets.)

GNK 5

GNK 6

GNK 7

GNK 8

GNK 9

GNK 10

Gases Nutrients Hormones Heat Productive substances Clotting material

GNK 11

Respiration Nutrition Removal of waste products Regulation Of Body Temperature Hormones transportion Defense of body

GNK 12

HEMOSTASISHEMOSTASIS PlateletPlatelet FibrinogenFibrinogen SerumSerum

IMMUNOLOGYIMMUNOLOGY LymphocytesLymphocytes PHAGOCYTOSISPHAGOCYTOSIS LuecocytesLuecocytes

GNK 13

Events in Hemostasis 1) vasoconstriction 2) platelet plug formation 3) blood clotting

GNK 14

GNK 15

1) Acitvation of plasminogen into plasmin2) Lysis of a clot or thrombus

GNK 16

1) Intrinsic – begins with activation of (Hagman) Factor XII

2) Extrinsic – starts with tissue injury and release of Tissue Factor (thromboplastin)

GNK 17

I.I. FibrinogenFibrinogenII.II. ProthrombinProthrombinIII.III. ThromboplastinThromboplastinIV.IV. Ca++Ca++V.V. Labile factorLabile factorVI.VI. Number no Number no

longer usedlonger usedVII.VII. Stable factorStable factor

viii.viii. Antihaemophilic Antihaemophilic factorfactor

ix.ix. Christmas factorChristmas factorx.x. Stuart-prower Stuart-prower

fcatorfcatorxi.xi. PTAPTAxii.xii. Hagman factorHagman factorxiii.xiii. Fibrin Fibrin

stabilizing stabilizing factorfactor

GNK 18

BLOOD CLOT

GNK 19

1) Menstruation at regular cyclic intervals but with excessive flow and duration

2) Total blood loss exceeding 80ml per cycle or menses lasting longer than 7 days

GNK 20

Organic causes 1)Infections= STDs 2)PIDs

Coagulation disorders Hepatic failure

GNK 21

Hypothyriodism Hyperthyriodism Anovulatory cycles

GNK 22

Uterine fibroids Endometrial hyperplasia

GNK 23

IUDs Steriod hormones Anticoagulatns PG E Progesterone

GNK 24

A)Drug treatment 1)NSAIDs (20-24%) 2)Antifibrinolytics (Tranexamic acid

58%) B)Hormones (progesterone30%)

(COCP 43%) C)Surgical options(D&C)

(Hysterectomy)

GNK 25

Synthetic amino acid Tranexamic acid Antiplasminic Absorption 30-50% (oral) PHL ~1.4h Excreted unchanged through kidney

GNK 26

Maxna inhibits conversion of plasminogen to plasmin by blocking the lysine binding sites of plasminogen, hence prevents breakdown of clot.

GNK 27

Tissue ThromboplastinTissue Thromboplastin BloodBlood ThromboplastinThromboplastin

ProthrombinProthrombin

ThrombinThrombin

FibronogenFibronogen Fibrin or ClotFibrin or Clot

Tisse ActivitorTisse Activitor Blood ActivitorBlood Activitor

PLASMINOGENPLASMINOGEN

PLASMINPLASMIN

F.D.PF.D.P

PROTHROMBINPROTHROMBIN

FIBRINOGENFIBRINOGEN FIBRIN OR CLOTFIBRIN OR CLOT

TISSUE TTHROMBOPLASTINTISSUE TTHROMBOPLASTIN

THROMBINTHROMBIN

PLASMINOGENPLASMINOGEN

PLASMINPLASMIN

F.D.PF.D.P

BLOOD ACTIVITORBLOOD ACTIVITOR

BLOOD THROMBOPLASTINBLOOD THROMBOPLASTIN

TISSUE ACITVATORTISSUE ACITVATOR

COAGULATION & FIBRINOLYTIC SYSTEMCOAGULATION & FIBRINOLYTIC SYSTEMGNK 29

GNK 30

Lysine Binding Lysine Binding SiteSite

FIBRINFIBRIN

GNK 31

PlasminogenPlasminogentPAtPA

FibrinFibrin

Maxna blocks lysing-binding

site and prevents bleeding

GNK 32

To prevent blood loss in DUB IUd PPh APH During and after surgery. In trauma

GNK 33

Maxna capsulesMaxna capsules Moderate bleeding= 250-500mg 3-4

times daily Severe bleeding= 500-1000mg 3-4

times daily

InjectionInjection 250-500mg I.V or I.M 1-2 times daily.

GNK 34

Generally well tolerated May cause G.I. disorder, nausea,

vomiting, and headache after oral administration.

Increased risk of adverse thrombotic events

No increase risk of DVT.

GNK 35

Maxna capsules: 250mg *20’s Maxna capsules:500mg*20’s Maxna injection:500mg*10’s

GNK 36

THANK YOU.THANK YOU.

GNKGNK

By Gul Nawaz Khangulnawazpk@gmail.com0333-9151163

3737